Heart surgery drug trial aims to stop kidney failure
NCT ID NCT05568160
Summary
This study is testing whether using the drug vasopressin to maintain blood pressure after heart surgery is better at preventing kidney failure or death than the standard drug, noradrenaline. It involves 840 adults at high risk for kidney problems who are having planned heart surgery using a heart-lung machine. Patients are randomly assigned to receive one of the two drugs, and neither they nor their doctors know which one they are getting.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASOPLEGIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, France
Conditions
Explore the condition pages connected to this study.